The Journal of Emerging Research in Cancer Pharmacotherapy (JERCP) is a leading international, peer-reviewed, open-access journal dedicated to publishing innovative and impactful research in the field of oncology pharmacology. Published by JAG Unified International, JERCP serves as a vital resource for scientists, clinicians, academic scholars, and healthcare professionals involved in cancer drug research and therapy.
Our Mission
Our mission is to foster cutting-edge discoveries and provide a credible platform for the dissemination of research that advances our understanding and treatment of cancer through pharmacological interventions. We aim to promote dialogue among researchers, support evidence-based clinical practice, and contribute to global improvements in cancer care.
What We Publish
JERCP welcomes a broad spectrum of contributions including:
- Original Research Articles
- Systematic Reviews and Meta-Analyses
- Case Reports and Clinical Studies
- Short Communications
- Perspectives and Commentaries
- Special Issues on Emerging Topics in Oncology Pharmacotherapy
All submissions undergo a rigorous double-blind peer review process to ensure scientific quality and integrity.
Areas of Focus
- Anticancer Drug Development
- Chemotherapy, Targeted and Immunotherapies
- Clinical Pharmacology in Oncology
- Cancer Pharmacogenomics and Biomarkers
- Drug Resistance Mechanisms
- Palliative and Supportive Oncology Pharmacotherapy
- Complementary and Integrative Approaches
Global Reach
JERCP is committed to providing unrestricted access to research outputs, fostering academic collaboration across countries, and supporting the dissemination of knowledge to both developed and developing regions.
Indexing and Archiving
We are in the process of applying for indexing in major databases such as DOAJ, Scopus, and PubMed Central to enhance the discoverability and impact of the published research.
